Tracking blood sugar changes in women having fertility treatment
Watches blood sugar with a worn sensor in women having assisted reproduction.
Key facts
- Who runs it
- Shanghai 6th People's Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Glucose Pattern in Infertile Women Receiving Assisted Reproduction Using Continuous Glucose Monitoring
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 26 Mar 2025
- Expected to end
- 30 Apr 2027
- Type of study
- Interventional
- Treatments tested
- CGM
- Record updated
- 23 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women with infertility who will start their first or second IVF/ICSI cycle at the study center. They will wear glucose sensors during treatment.
- Age
- 18 to 40 years
- Sex
- Women only
- Disease stage
- Female infertility, first or second cycle of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI).
- Earlier treatment
- The chosen ovarian stimulation plan must be the GnRH antagonist regimen or the PPOS regimen. People who recently had glucocorticoid treatment or chemotherapy cannot join.
Main reasons for not taking part
- Recent infections (viral infections of the reproductive system such as HPV are allowed)
- Recent glucocorticoid treatment or chemotherapy
- Repeated implantation failure, repeated miscarriage, removal of one ovary, uterine malformations, or abnormal parental chromosomes (karyotype)
- Cannot tolerate or is allergic to the sensor's adhesive tape
- Serious skin disease around the sensor area, such as psoriasis vulgaris or bacterial skin infection
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Informed consent and voluntary participation in this study
- Age ≥ 18 years and ≤40 years old
- Infertile patients who will undergo their first or second cycle of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) at the study center
- The chosen ovulation promotion regimens is the GnRH antagonist regimen/progesterone-promoting ovulation under hyperprogesterone state (PPOS) regimen
Who cannot take part
- Recent glucocorticoid treatment or chemotherapy
- Recent infections (excluding viral infections of the reproductive system such as HPV)
- Clinical conditions affecting the outcome of assisted reproduction, including repeated implantation failure, recurrent spontaneous abortion, history of unilateral oophorectomy, uterine malformations, and parental karyotype abnormalities
- Participants were unable to tolerate tape adhesive around sensor placement area, or with medically documented allergy towards the adhesive (glue) of plasters, or with serious skin diseases (e.g. psoriasis vulgaris, bacterial skin diseases) around sensor placement area
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 40 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
No studies have been seen on glucose variation during medication for assisted reproduction. The aim of this study is to continuously observe glucose variation during assisted reproduction treatment using continuous glucose monitoring (CGM), and to further explore whether glucose variation will affect the outcomes related to assisted reproduction.
The group in the trial
- wearing continuous glucose monitoringsTreatment being tested
Patients will wear two FreeStyle Libre Pro Flash CGM (Abbott Diabetes Care, Alameda, CA, USA) to ensure continuous tracking of blood glucose levels at key time points throughout the ovarian stimulation.
Treatment: CGM
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Glucose Pattern in Infertile Women Receiving Assisted Reproduction: a Prospective Study Using Continuous Glucose Monitoring
- Plain-language title
- Tracking blood sugar changes in women having fertility treatmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Fit questions
- Built from NCT06863337, who can take part
- Record updated
- 23 December 2025